Antifungal susceptibilities of Cryptococcus neoformans.
Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from Thailand, Malawi, and the United States and found no evidence of resistance or MIC profile differences among the countries.
Archibald
Lennox K
LK
Natioanl Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Larchibald@rtix.com
Tuohy
Marion J
MJ
Wilson
Deborah A
DA
Nwanyanwu
Okey
O
Kazembe
Peter N
PN
Tansuphasawadikul
Somsit
S
Eampokalap
Boonchuay
B
Chaovavanich
Achara
A
Reller
L Barth
LB
Jarvis
William R
WR
Hall
Gerri S
GS
Procop
Gary W
GW
D000935:Antifungal Agents / Q000494:pharmacology*; D003455:Cryptococcus neoformans / Q000187:drug effects* / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests
D000935:Antifungal Agents